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From plants to humans, the ability to control infection at the level of an individual cell—a process termed cell-
autonomous immunity—equates firmly with survival of the species. Recent work has begun to unravel this
programmed cell-intrinsic response and the central roles played by IFN-inducible GTPases in defending
the mammalian cell’s interior against a diverse group of invading pathogens. These immune GTPases regu-
late vesicular traffic and protein complex assembly to stimulate oxidative, autophagic, membranolytic, and
inflammasome-related antimicrobial activities within the cytosol, as well as on pathogen-containing
vacuoles. Moreover, human genome-wide association studies and disease-related transcriptional profiling
have linked mutations in the Immunity-Related GTPase M (IRGM) locus and altered expression of guanylate
binding proteins (GBPs) with tuberculosis susceptibility and Crohn’s colitis.Introduction
Essentially all diploid cells are endowed with a capacity for self
defense. This type of host resistance, called cell-autonomous
immunity, is ubiquitous throughout both plant and animal king-
doms (Beutler et al., 2006). It is operationally defined by aminimal
set of germline-encoded antimicrobial defense factors that
enables an infected host cell to resist a variety of prokaryotic
and eukaryotic pathogens. In this respect, it functions not only
in cells of the immune system, but also in histogenetic lineages
as diverse as keratinocytes, endothelia, cardiac myocytes,
hepatocytes, enterocytes, astrocytes, tonsillar epithelia, fibro-
blasts, and neurons. Most importantly, cell-autonomous immu-
nity spans both the sensory apparatus used for microbial
detection and the effector mechanisms directly responsible for
microbial killing (MacMicking, 2012; Yan and Chen, 2012).
Given its evolutionary significance, it is remarkable how often
this form of somatic self-defense is either overlooked or under-
appreciated, but it remains obligate for host survival, especially
in lower organisms, where it serves as the primary if not sole
form of pathogen resistance (Medzhitov et al., 2012; Ronald
and Beutler, 2010). Much of that resistance relies on a pre-
existing RNA and protein repertoire mobilized within minutes of
infection (Yan and Chen, 2012). This basal repertoire is capable
of conferring cell-autonomous protection against a variety of
phytopathogens and a more limited set of metazoan pathogens
(Ronald and Beutler, 2010).
Once we move to higher species such as mammals, a second
mode of cell-autonomous immunity begins to emerge as a likely
consequence of the broader microbial challenge faced by many
chordates such as humans (Sabeti et al., 2006). This gene reper-
toire differs from the hard-wired circuitry of its predecessor by
the characteristic of inducibility. Here a new set of proteins are
transcriptionally elicited by activating stimuli such as cytokines
and microbial products, a response that is often more sustained
and expansive than that of its earlier counterpart, enlisting
hundreds of antimicrobial genes (MacMicking, 2012; Yan and
Chen, 2012).
Chief among the activating stimuli that remodel the mamma-
lian cell’s transcriptome is the interferon (IFN) cytokine family.432 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.IFNs serve as powerful signals for marshaling host defense
throughout the vertebrate kingdom. These cytokines induce
numerous gene families that encode effectors and associated
regulators to direct each protein’s microbicidal or static activity
(MacMicking, 2012). Prominent within this group is an IFN-
inducible GTPase superfamily that operates against several
microbial classes (MacMicking, 2004; Martens and Howard,
2006; Shenoy et al., 2007; Taylor et al., 2004). Over the past
few years, we have begun to understand how some of these
new IFN-inducible GTPases execute their functions as part of
a potent host defense program in several vertebrate species.
Likewise, disease-associated genetic variants have recently
surfaced within the human population that may predispose to
tuberculosis (TB) and Crohn’s disease. This updated review
highlights progress on these IFN-inducible GTPases and exam-
ines their cell-autonomous role at the interface of several host-
pathogen relationships.
The IFN-Inducible GTPase Superfamily
Bioinformatic analysis coupled to chromosomal mapping
recently led to assembly of the complete superfamily in two
mammalian species—humans and mice (Kim et al., 2011)
(Figure 1). This particular effort utilized pair-hidden Markov
model algorithms plus cosmid and BAC fragment hybridization
to validate members of this new family. It built on the pioneering
work of Bekpen et al. (2005) and some excellent in silico annota-
tions for two IFN-inducible GTPase subfamilies, notably the
immunity-related GTPases (IRGs) and guanylate binding pro-
teins (GBPs) (Degrandi et al., 2007; Kresse et al., 2008;
Olszewski et al., 2006; Shenoy et al., 2007). Besides humans
and mice, IFN-inducible GTPase annotations have now been
compiled for other primates, plus cows, dogs, rats, opossums,
cartilaginous fish, frogs, lizards, birds, and cephalochordates
such as Brachiostomata (Bekpen et al., 2005; Li et al., 2009).
Further studies have unearthed sporadic ancestral orthologs
as far back as Arabidopsis (e.g., AEC09593) (Lin et al., 1999),
suggesting resistance functions in these lower organisms that
have been refashioned in vertebrates to respond to cytokine
stimulation (MacMicking, 2012).
Figure 1. The IFN-inducible GTPase Superfamily in Humans and
Mice
(A) Phylogenetic tree of the IFN-inducible GTPase superfamily encompassing
the four subfamilies: 21–47 kDa IRGs, 65–73 kDa GBPs, 72–82 kDa MX
proteins, and the 200–285 kDa GVINs. Bracketed names depict former
assignations prior to the currently adopted MGI nomenclature, except for Lirg
bidomain proteins. Two IRGM and Gbp5 isoforms are included, along with
a Gbp1 (Gbp2ts1) transpliced isoform (Kim et al., 2011). Selected H-Ras and
dynamin GTPases are shown for G domain comparison (EGA package MEGA
v4.0.). The scale bar indicates substitutions/site.
(B) Structural models of prototypic IRG, GBP, and MX proteins based on
crystallographic deposits showing the overall bidomain organization com-
posed of an N-terminal G domain (GD) and C-terminal helical domain (CTHD).
In the case of murine Irga6, a short intervening N-terminal helical domain
(NTHD) precedes the CTHD. Protein data bank (PBD) codes for the individual
proteins are given below.
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least 47 members in humans and mice (Kim et al., 2011)
(Figure 1). EachGTPase can be grouped into one of four subfam-
ilies on the basis of paralogy and molecular mass. These include
the 21–47 kDa IRGs, 65–73 kDa GBPs, 72–82 kDa myxoma (MX)
resistance proteins, and 200–285 kDa very large inducible
GTPases (VLIGs/GVINs) (MacMicking, 2004; Martens and
Howard, 2006).
For the IRG and GBP subfamilies, the majority of genes reside
in chromosomal clusters that are syntenic across species
(Bekpen et al., 2005; Degrandi et al., 2007; Kresse et al., 2008;Li et al., 2009; Olszewski et al., 2006; Shenoy et al., 2007). An
exception is the mouse IRG cluster on chromosome 11, where
only a single shortened IRGM gene is present on human chromo-
some 5q33.1 after deletion of the remaining family members by
insertion of an ERV9 U3 LTR retroelement (Bekpen et al., 2005,
2009). Here three mouse Irgm loci (Irgm1–Irgm3) are replaced
by a related prosimian precursor, IRGM9, which through a series
of truncation and resurrection events yield the IRGM locus in
humans and anthropomorphs such as gorillas and chimpanzees
(Bekpen et al., 2009) (Figure 1). Hence, the hominoid IRG genes
have been heavily trimmed during evolution, although alterna-
tive mRNA splicing may partially compensate for this loss by
generating several 21 kDa IRGM isoforms (IRGMa, IRGMb,
IRGMc/e, IRGMd in humans) with discrete functions (Brest
et al., 2011; Singh et al., 2010). The human GVINP1 locus has
also undergone some degree of pseudogenization compared
with the corresponding murine Gvin genes (Klamp et al., 2003).
In most other cases, however, gene expansion rather than
contraction predominates, probably driven by duplicative events
in response to the evolutionary pressure exerted by intracellular
pathogens (Shenoy et al., 2007). This has led to high degrees of
homology within subfamilies, especially across the catalytic G
domain.
IFN-Inducible GTPases: Design and Distribution
Crystal structures for several IFN-inducible GTPases reveal
a bidomain architecture consisting of a globular N-terminal G
domain followed by a C-terminal helical domain (CTHD) (Gao
et al., 2010; 2011; Ghosh et al., 2004; Prakash et al., 2000)
(Figure 1). This configuration allied with biochemical similarities
leads to their being grouped together with members of the
dynamin-like family of proteins, which in mammals includes
dynamins, mitofusin, atlastins, optic atrophy-1 (OPA1), and other
dynamin-like proteins (DRPs) (Ferguson and De Camilli, 2012;
Praefcke and McMahon, 2004). This family governs a variety of
cellular functions, from budding and fusion of transport vesicles
to organelle division and cytokinesis. They normally exhibit high
intrinsic rates of GTPase activity (kcat 20–250 min–1), low mM
substrate affinity, and nucleotide-dependent self-assembly to
generate >0.5–1 MDa complexes in cells. Hence, they are
‘‘large’’ GTPases that operate either as mechanoenzymes or
as assembly platforms to orchestrate disparate functions. In
contrast, the smaller 20–30 kDa H-Ras and heterotrimeric G
proteins operate as molecular ‘‘switches,’’ helping to relay up-
stream signals to downstream effectors with each cycle of
GTP hydrolysis (Ferguson and De Camilli, 2012; Praefcke and
McMahon, 2004).
While many IFN-inducible GTPases adhere to the self-
catalyzing and GTPase-dependent assembly principles of the
dynamin family, some do not. For example, the smaller IRG
proteins exhibit low intrinsic rates of GTP hydrolysis and are
often GDP bound, suggesting that they could enlist guanine
nucleotide exchange factors (GEFs) to displace GDP and
possibly GTPase-activating proteins (GAPs) to accelerate hydro-
lysis, like the H-Ras GTPases (Hunn et al., 2008; Papic et al.,
2008; Tiwari et al., 2009; Uthaiah et al., 2003). Alternatively,
some IRGs may undergo G domain dimerization like other non-
Ras GTPases to elicit GAP activity (Gasper et al., 2009; Uthaiah
et al., 2003). Specific IRG and GVIN genes also encode tandemCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 433
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2007), which in the case of GVINs lack some of the canonical
nucleotide-contact sites normally used for engaging its GTP
substrate (Figure 1). Lastly, certain GBPs (e.g., GBP5) undergo
tetramerization in the absence of GTP hydrolysis, while other
GBPs remain monomeric despite robust catalytic activity
(Shenoy et al., 2012; Wehner and Herrmann, 2010). Quite a
number of GBPs also generate GMP along with GDP, the only
known mammalian GTPases to do so (Colicelli, 2004; Praefcke
and McMahon, 2004). Hence, the IFN-inducible GTPases would
appear to defy simple enzymologic classification. They share
selected biochemical features of the dynamin protein family in
addition to displaying a uniqueness all their own.
Within the C-terminal region, a series of amphipathic a helices
are used for protein-lipid and protein-protein interactions; this
has been shown for both the IRGs and GBPs (Kim et al., 2011;
Martens et al., 2004; Tiwari et al., 2009). Specific GBPs also
harbor C-terminal CaaX motifs (GBP1, GBP2, GBP5) that can
be either completely or partially isoprenylated to provide anchor-
age to endomembranes on different organelles distributed within
the host cell (Britzen-Laurent et al., 2010; Modiano et al., 2005;
Tripal et al., 2007). Mutation of these residues often results in
dispersal throughout the cytoplasm and can interfere with anti-
microbial function, depending on the pathogen and the type of
niche in which it resides (Kim et al., 2011; Tietzel et al., 2009;
Virreira Winter et al., 2011). N-terminal glycines in some IRGs
are also myristoylated to aid membranous attachment, although
whether this modification is obligate for cell-autonomous
immunity is as yet unknown (Martens et al., 2004; Papic et al.,
2008).
All IFN-inducible GTPaseswith the exception of MX resistance
proteins are transcribed in response to type I (primarily IFN-a/b),
type II (IFN-g), and type III IFNs (IFN-ls). MX proteins are elicited
by type I and III IFNs but not IFN-g (Bekpen et al., 2005; Klamp
et al., 2003; Degrandi et al., 2007; Kim et al., 2011; Kresse
et al., 2008). Indeed, these IFN-induced GTPases represent
some of the most highly expressed IFN-induced target genes;
for example, the GBPs account for as much as 20% of all
proteins induced by IFN-g (Martens and Howard, 2006). More-
over, in keeping with their role in cell-autonomous immunity,
the IFN-inducible GTPases are expressed in most mammalian
cell lineages examined to date, a reflection in part of the wide-
spread distribution of different IFN receptors (MacMicking,
2004, 2012; Taylor et al., 2004). Certain GBPs also respond
to TNF-a and IL-1b in human endothelial cells and mouse
macrophages, further diversifying the inducible host response
(Degrandi et al., 2007; Tripal et al., 2007). This enables cell-
autonomous defense to intracellular bacteria, protozoa, and
viruses in diverse cell types and at selected stages of the path-
ogen life cycle. Many of their antimicrobial effects are facilitated
by direct targeting to the pathogen compartment, a character-
istic first noted for members of the IRG subfamily.
IRGs Target the Pathogen Vacuole
‘‘Sensing’’ the Pathogen Compartment
An early model proposed that the 21–47 kDa IRGs respond
primarily to signals emanating from compartmentalized patho-
gens (MacMicking, 2004; Taylor et al., 2004). Such com-
partments were thought to be structurally diverse, spanning434 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.bacterial phagosomes, chlamydial inclusion bodies, and proto-
zoan parasitophorous vacuoles. Detection of microbial, nonmi-
crobial, or even ‘‘altered/missing self’’ structures on these
compartments would enable IRGs to mobilize their effectors to
this site. Thus, the IRGs may bridge upstream sensory events
with downstream microbicidal activities in a way that helps
decode the language of vacuolar pathogen recognition.
Support for this idea came from examining Irgm1 (formerly
lipopolysaccharide-responsive gene of 47 kDa [LRG-47])
in macrophages infected with Mycobacterium tuberculosis
(MacMicking et al., 2003). M. tuberculosis phagosomes were
found to recruit Irgm1 that facilitated IFN-g-induced fusion of
this compartment with microbicidal lysosomes as shown by
a series of direct functional assays; such activity was impaired
in Irgm1–/– cells (MacMicking et al., 2003). Thereafter, several
groups analyzed the traffic of other IRGs and IFN-inducible
GTPases to different pathogen compartments.
Human IRGM along with its murine Irgm1 ortholog are
now known to be targeted to Listeria monocytogenes,Mycobac-
terium bovis, Mycobacterium tuberculosis, Salmonella typhiu-
murium, and most likely Crohn’s disease-associated adherent
invasive Escherichia coli (AIEC, which can replicate inside phag-
olysosomes) in monocytes, macrophages, and epithelial cells
(Figure 2) (Brest et al., 2011; Gutierrez et al., 2004; Jua´rez
et al., 2012; Lapaquette et al., 2010; McCarroll et al., 2008;
Shenoy et al., 2007; Singh et al., 2006; Tiwari et al., 2009). This
translocation increases when otherwise cytosolic bacteria
remain trapped inside vacuoles (e.g., Listeria mutants lacking
the pore-forming toxin, listeriolysin O) (Shenoy et al., 2007).
Likewise, mouse Irgm3, Irga6, and Irgb10 target inclusion bodies
harboring Chlamydia trachomatis and Chlamydia psittaci but not
Chlamydia muridarum, suggesting that the murine pathogen has
coevolved strategies to evade IRG pursuit (Al-Zeer et al., 2009;
Coers et al., 2008; Nelson et al., 2005).
Numerous IRGs also converge on vacuoles containing the
apicomplexan parasite, Toxoplasma gondii, in IFN-g-activated
mouse macrophages, fibroblasts, or astrocytes (Hunn et al.,
2008; Ling et al., 2006; Khaminets et al., 2010; Martens et al.,
2005). The Toxoplasma model has helped reveal sophisticated
molecular strategies used by both host and pathogen to gain
ascendency over one another. IRG targeting is only seen, for
example, with less-virulent type II and III forms of T. gondii
because virulent type I strains have acquired mechanisms to
interfere with IRG recruitment (Fentress et al., 2010; Fleckenstein
et al., 2012; Niedelman et al., 2012; Steinfeldt et al., 2010; Zhao
et al., 2009a, 2009b). Such interference relies on the combined
action of two secreted rhoptry proteins, ROP5 and ROP18.
The functional kinase ROP18 engages mouse Irga6 and Irgb6
via the pseudokinase ROP5 to maintain these IRGs in the non-
active GDP-bound conformation (Fentress et al., 2010; Flecken-
stein et al., 2012; Niedelman et al., 2012; Steinfeldt et al., 2010).
ROP5 binding in particular exposes active site threonines on the
GTPase switch I loop that are then targeted by ROP18 for phos-
phorylation and inactivation, which prevent Irga6 and Irgb6
targeting to the parasitophorous vacuole (Fentress et al., 2010;
Fleckenstein et al., 2012; Niedelman et al., 2012; Steinfeldt
et al., 2010). Thus, pathogen strategies directed against IRG
recruitment underscores its importance for cell-autonomous
control in different vertebrate hosts.
Figure 2. IRGs Target Intracellular
Pathogens
(A) Irgm1 targets the mycobacterial vacuole.
Endogenous Irgm1 (green) translocates to the
nascent phagocytic cup (arrows) engulfing Myco-
bacterium bovis BCG (red) in IFN-g-activated
mouse bone marrow-derived primary (left) or
RAW264.7 (right) macrophages shown by con-
focal microscopy. The scale bar represents 2 mm.
DIC, differential interference contrast (Tiwari et al.,
2009).
(B) Irgm1 recruitment to the phagocytic cup
occurs within minutes of mycobacterial uptake.
Live meta confocal imaging of IFN-g-activated
macrophages expressing fluorescent Irgm1
(green), the pleckstrin homology (PH) domain of
general receptor for phosphoinositides-1 (GRP1,
which detects PtdIns3,4,5P3; red), and M. bovis
BCG (in bluewith arrow). Boxed region, Irgm1- and
PtdIns3,4,5P3-enriched pseudopod engulfing
bacteria.
(C) Left: Robust lipid binding of Irgm1 directly to
PtdIns3,4,5P3 and PtdIns3,4P2 in a gel overlay
assay that is lost for the Irgm1 aK helical mutant in
which amphipathicity of this region is destroyed
(Irgm1F362E,R367E) (Tiwari et al., 2009). Right:
Computer-generated Irgm1 model based on
crystallized dimeric Irga6 (PBD code ITQ6) show-
ing the membrane-accessible aK helix and
mutated amphipathic residues within it.
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What are the compartmental signatures sensed by IRGs?
To date, little is known about the molecular determinants of
vacuolar recognition, although work with Mycobacterium bovis
BCG found that host phosphatidylinositide lipids (PtdIns3,4P2
and PtdIns3,4,5P3) generated by class I phosphatidylinositide
kinases (PI3Ks) can act as a spatial cue for soliciting Irgm1 to
the phagocytic cup within minutes of bacterial uptake (Figure 2).
Irgm1 directly binds PtdIns3,4,5P3 and PtdIns3,4P2 via
a C-terminal amphipathic helix (aK); mutation of this region or
inhibition of class I PI3Ks impaired its targeting to plasma
membrane-derived phagosomes in IFN-g-activated macro-Cell Host & Microbe 12,phages (Tiwari et al., 2009) (Figure 2).
Here lipid binding also served a second
function, helping to derepress an intra-
molecular inhibition of the aK helix to
facilitate GTP hydrolysis and transition
state binding to its effector proteins
once Irgm1 had reached the mycobacte-
rial phagosome (Tiwari et al., 2009). Thus,
certain host lipid species not only act as
a recognition motif but may also trigger
an allosteric switch in Irgm1 to start
assembling the prefusogenic machinery
on the bacterial vacuole.
Evolution of a lipid-sensing domain in
the IRGs fits with other mammalian
GTPases; inspection of 125 Ras, Rab,
Arf, and Rho GTPases, for example,
found that nearly one-third contained
C-terminal amphipathic helices that
bound PtdIns3,4,5P3 and PtdIns4,5P2
for redirection to the plasma membrane(Heo et al., 2006). Because vacuolar pathogens like Salmonella
typhimurium secrete phosphatases (SopB) that dephosphor-
ylate these PtdIns in establishing their replicative niche
(Hernandez et al., 2004), Irgm1 may be forced to recognize
other lipid species or use different interaction domains besides
the aK helix to target such bacteria as part of a coevolutionary
arms race (Kuijl and Neefjes, 2009). Consistent with this
idea, Irgm1 also binds diphosphatidylglycerol (DPG, or car-
diolipin) which is a common inner membrane constituent of
many gram-negative and gram-positive bacteria that is found
on their phagosomes (Matsumoto et al., 2006; Tiwari et al.,
2009).October 18, 2012 ª2012 Elsevier Inc. 435
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the regions used to engage this phospholipid are different,
however, as it lacks the Irgm1-related CTHD (Bekpen et al.,
2005, 2009). IRGMd may instead enlist N-terminal helices or
even acquire a lipid-sensing domain in trans via its partners,
since IFN-inducible GTPases interact with each other to regulate
traffic to vacuolar compartments (Hunn et al., 2008; Khaminets
et al., 2010; Traver et al., 2011; Virreira Winter et al., 2011).
Whether other host or pathogen lipid species besides
PtdIns3,4,5P3, PtdIns4,5P2, and DPG serve as intracellular
PAMPs to recruit IRGs remains to be tested. So, too, does the
possibility that specific lipids impose membrane curvature
profiles that act as a second level of IRG recognition for sensing
and discriminating between different pathogen compartments.
Consequences of IRG Recruitment
Once IRGs reach the pathogen vacuole, what are the conse-
quences for cell-autonomous immunity? Studies of AIEC, Chla-
mydia, Mycobacteria, Salmonella, and Toxoplasma have begun
to shed light on this issue (Al-Zeer et al., 2009; Brest et al.,
2011; Hunn et al., 2008; Khaminets et al., 2010; Lapaquette
et al., 2010; Nelson et al., 2005; Singh et al., 2006; Tiwari et al.,
2009; Zhao et al., 2008). IRGs serve distinct roles depending
on which biochemical class—GKS or GMS—they belong to.
This functional classification developed by Hunn and coworkers
(2008) is based on the presence of canonical (lysine, K) or non-
canonical (methionine, M) G1 motifs (GX4G[K/M]S/T) within the
conserved N-terminal catalytic G domain. Lysine substitution
by methionine does not appear to adversely affect enzyme
activity (Taylor et al., 1996; Tiwari et al., 2009) but nonetheless
leads to divergent biological activities. IRGs of the GMS
subclass (IRGMa–IRGMd in humans, Irgm1–Irgm3 in mice)
appear to be intrinsic regulators, helping control the antimicro-
bial activities of their respective effectors, which include SNARE
adaptor and autophagy proteins as well as GKS-containing IRGs
and possibly even GBPs (Al-Zeer et al., 2009; Hunn et al., 2008;
Khaminets et al., 2010; Lapaquette et al., 2010; Nelson et al.,
2005; Singh et al., 2006; Tiwari et al., 2009; Traver et al., 2011;
Zhao et al., 2008).
During infection with AIEC, Mycobacteria or Salmonella
serovars, human IRGM or its murine Irgm1 ortholog recruit auto-
phagic (e.g., MAP1/LC3) and SNARE adaptor (e.g., Snapin)
proteins to assemble fusogenic and possibly biogenesis of
lysosome-related organelle complexes (BLOCs) in a pathogen-
specific fashion for lysosomal targeting, since IFN-g-induced
autophagosome formation appears ostensibly normal in unin-
fected Irgm1–/– macrophages (Brest et al., 2011; Jua´rez et al.,
2012; Gutierrez et al., 2004; Lapaquette et al., 2010; MacMicking
et al., 2003; Matsuzawa et al., 2012; Singh et al., 2006, 2010;
Tiwari et al., 2009; Traver et al., 2011). The human IRGM locus
generates at least five messenger RNA (mRNA) transcripts en-
coding four IRGM isoforms: IRGMa–IRGMd (Bekpen et al.,
2005; 2009). IRGMd is posited to translocate to mitochondria
where it causes fission to elicit autophagy against mycobacterial
infection (Singh et al., 2010), a process that could underlie auto-
phagic responses to Salmonella typhimurium and AIEC, as well
(Brest et al., 2011; Lapaquette et al., 2010; McCarroll et al.,
2008). Other human IRGM isoforms appear to target the
M. tuberculosis phagosome directly when elicited through the
innate immune receptor NOD2 by its ligand muramyl dipeptide436 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.in human alveolar macrophages (Jua´rez et al., 2012). Lastly,
murine Irga6 binds the microtubule-binding protein Hook3
(Kaiser et al., 2004) that is otherwise disabled by the Salmonella
type III secretion effector, SpiC, to prevent phagolysosome
fusion (Shotland et al., 2003); whether this binding restores
bacterial killing, however, has yet to be tested. Several IRGs
thus appear to help deliver phagocytosed bacteria via a number
of interaction partners and pathways to lysosomes.
For Chlamydia serovars, mouse Irgm3 acts as a noncanonical
guanine nucleotide dissociation inhibitor (GDI) that releases
membranolytic GKS-containing IRGs like Irga6 and Irgb10 to
directly disrupt the Chlamydial inclusion body (Al-Zeer et al.,
2009; Coers et al., 2008). Additionally, Irgm3 and Irga6 intercept
sphingomyelin-containing exocytic vesicles (Nelson et al., 2005)
or bind to adipophilin/ADRP to regulate the stability of lipid
bodies (Bougne`res et al., 2009), which store neutral lipids and
normally provide nutrition for the chlamydial inclusion (Saka
and Valdivia, 2012). Loss of these IRG activities renders
Irgm3–/–, Irga6–/–, and Irgb10–/– fibroblasts susceptible to infec-
tion with C. trachomatis or C. psittaci (Bernstein-Hanley et al.,
2006; Coers et al., 2008; Miyairi et al., 2007).
The regulatory functions of IRGM proteins extend to Toxo-
plamsa gondii tachyzoites where a hierarchical model for inter-
actions among IRGs themselves was first uncovered (Hunn
et al., 2008). Here Irgm1–Irgm3 allow release and sequential
accumulation of GKS IRGs—specifically, Irgb6, Irgb10, Irga6,
and Irgd in that order—on the parasitophorous vacuole (Hunn
et al., 2008; Khaminets et al., 2010). These functions are partly
shared with the autophagy protein, ATG5, and members of the
GBP family that facilitates IFN-g or IFN-g/LPS-induced Irga6/
Irgb6 trafficking to the T. gondii vacuole in a noncanonical
fashion (Khaminets et al., 2010; Yamamoto et al., 2012; Zhao
et al., 2008). IRG targeting becomes detectable over a 10–
20 min period before progressive accumulation up to 90 min,
when the GTPase-driven oligomerization of different GKS IRGs
leads to membrane vesiculation and disruption akin to the tubu-
lating activities of other dynamin-like proteins (Ling et al., 2006;
Martens et al., 2005; Zhao et al., 2009a, 2009b). This membrane
disruption is reported to have different cell-autonomous fates
depending on host cell type. In activated fibroblasts it leads to
necroptosis (Zhao et al., 2009b), whereas in cytokine-stimulated
macrophages the damaged parasite organelle appears to
undergo autophagic elimination (Ling et al., 2006).
GMS-containing IRGs thus coordinate multiple classes of
effectors—SNARE and BLOC adaptors, autophagy and lipid
droplet proteins, GKS-containing IRGs, and even GBPs—to
promote cell-autonomous immunity to intracellular pathogens
occupying different vacuolar habitats. Such widespread involve-
ment likely contributes to the pronounced susceptibility pheno-
types seen in several IRGM-deficient human and mouse hosts
(see MacMicking, 2012).
GBPs Target Both Vacuolar and Cytosolic Pathogens
Patrolling the Host Cell’s Interior
Interactions within and outside the GBP family enable these
65–73 kDa GTPases not only to patrol membrane-enclosed
pathogens like Chlamydia trachomatis, Mycobacterium bovis,
and Toxoplasma gondii but also alert the innate immune system
to cytosolically escaped microbes. GBPs normally partition
Cell Host & Microbe
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redirected to the pathogen compartment and to Listeria mono-
cytogenes, Shigella flexneri, and a subpopulation of Salmonella
typhimurium that have escaped their vacuole to replicate in the
cytosol (Degrandi et al., 2007; Kim et al., 2011; Kravets et al.,
2012; MacMicking, 2012; Tietzel et al., 2009).
GBP translocation requires nucleotide binding and catalytic
activity to help self-assemble these larger GTPases along with
their effector proteins (Kim et al., 2011; Kravets et al., 2012;
MacMicking, 2012; Tietzel et al., 2009; Virreira Winter et al.,
2011). Isoprenylation of human and mouse GBP1 and GBP2 is
also required to recruit these two GTPases, for example, to
M. bovis BCG, L. monocytogenes, and S. typhimurium but
not to T. gondii parasitophorous vacuoles (Kim et al., 2011;
MacMicking, 2012; Virreira Winter et al., 2011). This selectivity
is further evident for the kinetoplastid parasite Trypanosoma
cruzi, which fails to recruit mouse Gbp1 altogether in IFN-g-
activated macrophages (Virreira Winter et al., 2011). Such differ-
ential targeting probably reflects the membrane composition of
distinct compartments inhabited by specific pathogens as well
as the presence or absence of specific host components on
the bacterial envelope once they enter the cytosol (MacMicking,
2012). Again, targeting of GBPs to the site of pathogen
replication often appears requisite for subsequent antimicrobial
activity.
GBPs Assemble Pathogen-Specific Defense Complexes
What do the GBPs assemble on replicative vacuoles or deliver to
cytosolic pathogens? Recent work indicates that different
GBPs galvanize specific defense complexes that confer cell-
autonomous resistance in both locations. Identification of these
new GBP-mediated functions represent a major breakthrough
for the field of host defense, since the molecular mechanisms
employed by the atypical 65–73 kDa GTPases had remained
elusive for over two decades.
A family-wide screen combining three independent loss-of-
function approaches—siRNA silencing, dominant-negative
inhibition and chromosomal deletion—recently uncovered path-
ogen-specific involvement for four members against M. bovis
BCG and L. monocytogenes (Kim et al., 2011). Here Gbp1,
Gbp6, Gbp7, and Gbp10 promoted cell-autonomous defense
in IFN-g-activated macrophages while the generation of Gbp1-
deficient mice revealed loss of bacterial control for these two
pathogens in vivo (Kim et al., 2011).
Subsequent studies have also reported Toxoplasma suscepti-
bility in mice with single deletions at the Gbp2 locus and en bloc
deletion the entire Gbp cluster (Gbp2ps, Gbp2, Gbp1, Gbp3,
Gbp7, Gbp5) on chromosome 3H1 (Gbpchr3) (Kravets et al.,
2012; Yamamoto et al., 2012) (Figure 3). Despite lacking Gbp2,
experiments in Gbpchr3 mice suggested Gbp1, Gbp5, and
Gbp7 are more important based on reconstitution of individual
Gbps inGbpchr3 cells (Yamamoto et al., 2012). Likewise, suscep-
tibility to L. monocytogenes in Gbp1–/– and Gbp5–/– mice was
absent from Gbpchr3 animals that also lack both Gbps; here
differences likely reflect the adminstrative route used, namely,
oral versus peritoneal inoculation (Kim et al., 2011; Shenoy
et al., 2012; Yamamoto et al., 2012). Nonetheless, the fact that
Gbp1–/–, Gbp2–/–, and Gbp5–/– single knockouts differ from
Gbpchr3 mice against some of the same pathogens (T. gondii,
L. monocytogenes) may indicate disrupted regulatory interac-tions among family members (Britzen-Laurent et al., 2010;
VirreiraWinter et al., 2011) or nonspecific intergenic effects being
associated with the 173 kb deletion in Gbpchr3 mice (Yamamoto
et al., 2012). Clean chromosomal deletions of each Gbp loci will
thus probably be needed to correctly ascribe functions to
individual members.
Protein-protein interaction screens found Gbp1 and Gbp7
assembled oxidative and autophagic complexes for bacterial
elimination (Kim et al., 2011) (Figure 3). Gbp7 bound NADPH
oxidase, a membrane complex that generates superoxide
(O2
–), and Atg4b, a cysteine protease required for autophagy,
while Gbp1 engaged the ubiquitin-binding protein p62/
Sequestosome-1. Gbp7 could help form the NADPH oxidase
by acting as a bridging protein between the membrane-associ-
ated heterodimer, p22 phox-gp91phox, and cytosolic p67phox to
assemble the holoenzyme on bacterial phagosomes and endo-
somal vesicles targeting the pathogen vacuole (Kim et al.,
2011). Gbp7 also recruits Atg4b to help drive the extension of
autophagic membranes around bacteria within damaged
compartments, an activity that is likely to require Gbp7 self-
assembly. Notably, Atg4b was found to be recruited to
T. gondii vacuoles, although this was not affected in Gbpchr3
peritoneal macrophages, similar to that seen for the oxidative
burst (Kim et al., 2011; Yamamoto et al., 2012). Such differences
may arise from pathogen-specific responses for Gbp7 against
Mycobacterium versus Toxoplasma, elicited versus resting cells,
or the loss-of-function strategy employed (Dupont and Hunter,
2012). Gbp1 bound p62/Sequestosome-1 to help deliver ubiqui-
tinylated cargo to autolysosomes and possibly respond to
bacteria ‘‘marked’’ by ubiquitin in the cytosol, where it solicits
other GBPs as effectors (Kim et al., 2011; MacMicking, 2012).
This interdependence between GBP family members is simi-
larly noted against T. gondii, where Gbp1 can recruit Gbp2 and
Gbp5 as downstream partners (Virreira Winter et al., 2011). A
pan-Gbp1-5 antibody also retrieved endogenous Irgb6, sug-
gesting that certain GKS IRGs are recruited as potential
membranolytic effectors (Yamamoto et al., 2012), although their
absence from the human genome indicates that human GBPs
probably operate via different mechanisms in IFN-g-activated
cells (Bekpen et al., 2005; Niedelman et al., 2012). Notably,
virulent type I T. gondii strains strongly interfere with GBP
recruitment, a process that enlists the parasite rhoptry proteins
ROP16, ROP18, and the parasite-dense granule protein,
GRA15 (Degrandi et al., 2007; Virreira Winter et al., 2011).
Whether ROP16 and ROP18 kinases phosphorylate the analo-
gous switch I region in GBPs to turn off this class of host defense
GTPases akin to the IRGs awaits experimental validation.
Besides bacteria and protozoa, GBPs also promote cell-
autonomous defense against viruses. This antimicrobial profile
differs from the IRGs that appear to lack intrinsic antiviral activity
but resembles the related IFN-inducible MX GTPases that are
potent viral restriction factors, especially against orthomyxovi-
ruses such as influenza A (Haller and Kochs, 2011). Human
GBP1, GBP3, and a C-terminally truncated GBP3 splice isoform
designated GBP3DCwere recently found to inhibit influenza A in
IFN-g-activated lung epithelia as well (Nordmann et al., 2012).
Antiviral activity required the G domain and was dependent on
GTP binding but not hydrolysis, suggesting that oligomerization
was essential for repression of the influenza PB1, PB2, and PACell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 437
Figure 3. Members of the GBP Family Assemble Defense Complexes
(A) Chromosomal configuration of human and mouse GBP families showing inverted and direct synteny of mouse chromosome 3H1 and 5E5 with human
chromosome 1q22.1 (Kim et al., 2011). BAC clones spanningGBP clusters that were used for assembly are listed in blue font. Red circles designate centromeric
orientation.
(B) Gbp7 (green) also targetsM. bovis BCG (red) within 30 min as seen via live imaging in IFN-g-activated mouse macrophages. Relative fluorescent units (RFU)
for boxed insets are shown below.
(C) Left: Retrieval of endogenous NADPH oxidasemembrane-spanning gp91phox and p22phox subunits by theGbp7 C-terminal helical domain (CTHD) specifically
from IFN-g-activated macrophage lysates in silver-stained gels. Individual mass spectrometric peptides are shown alongside in red, with overlapping peptides in
green. Right: Gbp7 (red) and p22phox (blue) on vesicles targeting M. bovis (green) in IFN-g-activated macrophages (inset squares shown below). The scale bar
represents 10 mm (Kim et al., 2011).
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Reviewpolymerase complex that leads to reduced viral RNA and protein
synthesis (Nordmann et al., 2012). Thus, a recurring biochemical
feature of this superfamily—self-assembly—appears important
for the antimicrobial activity of many GBPs against at least three
pathogen classes: bacteria, protozoa, and viruses.438 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.GBP5-Mediated Inflammasome Activation
Another recent discovery is the involvement of GBP5 in assem-
bling the NLRP3 inflammasome, a complex that senses micro-
bial molecules and stimulates caspase-1 activation and proin-
flammatory cytokine production. Interestingly, GBP5 mediated
Figure 4. GBP5 as an Inflammasome
Activator During Cell-Autonomous Host
Defense
(A) Schematic model of IFN-g-induced GBP5 that
helps assemble the NLRP3 inflammasome in
response to whole bacteria, their TSS-secreted
products, and cell wall fragments (lipopolysac-
charide [LPS], muramyl dipeptide [MDP], and
g-D-glutamyl-meso-diaminopimelic acid [ieDAP])
within the cytosol. These activating signals are
accompanied by potassium efflux (K+) and mobi-
lize tetrameric GBP5 bound via its G domain (GD)
to the pyrin domain of NLRP3 (NLRP3PYD) to begin
assembling the inflammasome complex that in-
cludes the adaptor protein, Asc, which bridges
NLRP3 and the zymogen, procaspase-1. This
GBP5-dependent assembly ultimately leads to
caspase-1 autoproteolysis and activation to
cleave its procytokine substrates, interleukin-1b
and interleukin-18 (Shenoy et al., 2012; Caffrey
and Fitzgerald, 2012).
(B) Formation of a GBP5 scaffold around the
NLRP3-ASC inflammasome in response to LPS
and the K+ ionophore, nigericin, in human HeLa
cells reconstituted with ASC (blue), GBP5 (red),
and NLRP3PYD (green) (Shenoy et al., 2012). The
scale bar represents 10 mm. Boxed insets are
shown below.
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like bacteria and their cell-wall components but not to sterile
agonists or adjuvants such as alum (Shenoy et al., 2012)
(Figure 4). GBP5 is the first noncanonical protein to exhibit this
activity, leading to a reappraisal of the way in which inflamma-
somes are regulated in immunologically activated cells to
combat infection (Caffrey and Fitzgerald, 2012).
Evidence of this relationship came from large-scale in silico
screens designed to mine interdomain similarities across
574 GBP-related sequences from 91 taxa: it retrieved domains
found in NOD-like receptor (NLR) proteins fused to ancestral
GBPs from lower organisms (Shenoy et al., 2012). This sug-Cell Host & Microbe 12,gested that interactions between the
GBPs and inflammasome-related NLRs
could exist in higher species such as
mammals, except that here the relevant
domains would be separated onto
seemingly unrelated proteins through
evolutionary divergence. Probing of the
interdomian profiles of lower organisms
thus enabled functional relationships to
be established in higher species that
would otherwise remain imperceptible
because they operate over large protein
distances.
Subsequent analysis found human
GBP5 and its murine Gbp5 ortholog
were critical for NLRP3 but not AIM2
or flagellin-dependent NLRC4 inflam-
masome activation in IFN-g-activated
macrophages and in Gbp5-deficient
mice (Figure 4). The stimulus-dependent
role of GBP5 encompassed live Salmo-
nella and Listeria infection, as well astheir cell wall components (LPS, MDP), but not crystalline
agents that also activate the NLRP3 inflammasome via
a different pathway involving lysosomal rupture (Shenoy
et al., 2012; Caffrey and Fitzgerald, 2012). How this selectivity
is imposed remains unknown, but it leads to NLRP3 assembly
by GBP5 tetramerization as a bound partner to activate
procaspase-1 (Shenoy et al., 2012) (Figure 4). Thus, GBP5
represents a unique ligand-specific rheostat for inflammasome
activation that links earlier observations on its role during
Salmonella typhimurium-induced pyroptosis to help restrict
infection in a cell-autonomous manner (Rupper and Cardelli,
2008).October 18, 2012 ª2012 Elsevier Inc. 439
Figure 5. Disease-Associated Polymorphisms in the Human IRGM Locus
(A) Early observations of pulmonary TB susceptibility in experimental animals harboring a chromosomal deletion of the Irgm1 locus after aerogenic infection with
M. tuberculosis (MacMicking et al., 2003) are now emerging for the IRGM locus in the human population (see B). Wild-type and Ifngr1 (ligand-binding chain of the
IFN-g receptor)-deficient mice served as positive and negative controls, respectively, in these initial experiments. The scale bar represents 1 cm.
(B) Configuration of the IRGM locus on human chromosome 5q33.1 that yields five splice mRNA isoforms (IRGMa–IRGMe) predicted to encode four different
IRGM proteins (IRGMa, IRGMb, IRGMc/e, and IRGMd) (Bekpen et al., 2005; 2009). Upstream ERV9 retroelement insertion plus Alu repeats shown together with
the 20.1 kb deletion polymorphism in linkage disequilibrium with a coding SNP rs10065172 that results in reduced IRGM expression and susceptibility to both TB
and CD. Haplotypes at this nucleotide (313T/c) are selectively targeted by miRNA-196 to destabilize IRGM transcripts in intestinal epithelia and certain
nonintestinal cell types (McCarroll et al., 2008; Brest et al., 2011). Other disease-associated polymorphisms and their respective SNPs across the IRGM locus are
depicted.
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IFN-inducible MXGTPases differ from the IRGs and GBPs in that
they direct their antimicrobial activities almost exclusively to
viruses. Originally identified as an inherited trait conferring resis-
tance to influenza A as shown by susceptible mouse strains that
harbor deletions or nonsense mutations in the murine Mx1
(Myxoma resistance gene 1) locus, the MX proteins are now
established broad-spectrum antiviral proteins effective against
flu and influenza-like togaviruses, as well as bunyaviruses,
rhabdoviruses, and Thogoto, Coxsackie, and Hepatitis B viruses
(Haller and Kochs, 2011; MacMicking, 2012). Indeed, their
importance is perhaps best exemplified by the ability of a human
MX1 transgene to completely rescue mice lacking IFN type I
(IFNa/b) receptors from influenza infection, indicating that MX1
is sufficient to act autonomously without other type I IFN-
induced restriction factors (see Haller and Kochs, 2011).
More recently, crystallographic analysis has begun to unveil
the molecular mechanisms used by human MX1 at the atomic
level (Gao et al., 2010, 2011). Nucleotide-free structures of this
GTPase found three topographical domains: a globular
N-terminal G domain, an extended three helical bundle termed
the central bundle signaling element (BSE), and a stalk spanning
the middle and C-terminal GTPase effector domains (GEDs)
responsible for tetrameric self-assembly. Cooperative functions
between the BSE and GED promote oligomerization akin to the
dynamin family and are essential for antiviral function (Gao
et al., 2010, 2011). Hinges each side of the BSE enable MX1
mechanoenzyme movement that on the basis of minireplicon
systems are likely to assemble oligomeric rings around viral
nucleocapsid proteins bound by the MX1 stalk region to immo-440 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.bilize them (Haller and Kochs, 2011). An appealing feature of
this structural model is that it accommodates the known ability
of MX proteins to target different viruses independently of viral
nucleotide or sequence composition.
Human Genetics of the IFN-Inducible GTPases:
Tuberculosis, Crohn’s, and MicroRNAs
Recent human genetic studies implicate IRGM and several
GBPs in the protective or inflammatory immune response to
clinical tuberculosis (TB), findings consistent with the experi-
mentally determined in vivo roles for Irgm1 and Gbp1 against
M. tuberculosis and its close relative, M. bovis BCG (Feng
et al., 2004; Kim et al., 2011; MacMicking et al., 2003) (Figure 5).
Examination of IRGM variants in over 2,000 pulmonary TB
patients and their unaffected controls found increased risk
frequencies associated with the IRGM 2621TT genotype against
M. tuberculosis but not M. africanum clades in a Ghanese pop-
ulation (Intemann et al., 2009). TB susceptibility in African
Americans also segregates with single-nucleotide polymor-
phisms (SNPs) in IRGM (rs13361189 T/C and rs10065172 C/T)
that are in linkage disequilibrium with a 20 kb upstream deletion
(King et al., 2011), while a 1208 A/G allelic promoter polymor-
phism within this region match smear and/or culture-positive
TB in Beijing cohorts (Che et al., 2010) (Figure 5). Hence, alter-
ations in the IRGM locus may yield candidate susceptibility
profiles in diverse human populations against different myco-
bacterial species.
For the GBPs, recent genome-wide transcriptional profiling
found that patients undergoing active TB mobilized strong mod-
ular signatures within neutrophils dominated by IFN-induced
Figure 6. IFN-Inducible GTPases Confer Pathogen-Specific Host Defense
Naturally occurring and genetically engineered loss-of-function mutations in humans and mice reveal patterns of pathogen-directed immunity among the
IFN-inducible GTPase subgroups. IRG proteins appear to be heavily biased toward vacuolar bacteria and protozoa, while MX proteins almost exclusively inhibit
viruses. In contrast, the GBPs are required for cell-autonomous resistance against all three pathogen classes. Abbreviations are as follows: HBV57, hepatitis B
virus 57; HCV, hepatitis C virus; Mx1D390–631, congenital mouse Mx1 locus deletion encoding amino acids 390–631.
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the lungsof TB-infectedanimals (Berry et al., 2010;Marquis et al.,
2011). Extrapolating from studies of Gbp1–/– and Gbp5–/– mice,
such responses are likely to be protective overall; however,
persistent inflammasome activation may lead to pulmonary
damage (Kim et al., 2011; Shenoy et al., 2012). Whether distinct
GBP mutations influence human TB susceptibility like IRGM in
different ethnic groups or geographical locations has yet to be
investigated.
Comprehensive genome-wide association analysis has also
recently shown IRGM acts as a major predisposing locus for
Crohn’s disease (CD) (Craddock et al., 2010; Wellcome Trust
Case Control Consortium, 2007). Suprisingly, SNPs immediately
flanking IRGM on chromosome 5q33.1 have the strongest repli-
cating frequency and are associated with the upstream 20 kb
deletion (Parkes et al., 2007), a finding confirmed in multiple
CD studies (Khor et al., 2011) (Figure 5). This structural deletion
is in linkage disequilibrium with a coding SNP that affects
IRGM expression. Nucleotide 313T coding haplotypes are
‘‘risk’’ alleles that largely abolish IRGM expression in colonic
epithelia, which coincides with autophagy defects against
S. typhimurium or colitogenic AIEC, whereas the 313C ‘‘protec-
tive’’ haplotype generally exhibits higher IRGM levels and intact
autophagy responses (McCarroll et al., 2008). IRGM thus
appears to be necessary for cell-autonomous defense against
enteropathogens, although its expression is tightly controlled.
Recently, a specific microRNA, miR-196, was found to limit
IRGM expression in intestinal epithelia by binding the ‘‘protec-
tive’’ 313C allele since unchecked IRGM expression can lead
to dysregulated autophagic immunity against AIEC and induce
apoptosis (Brest et al., 2011) (Figure 5). Hence, epigeneticsilencing points to a complex regulatory circuit for IRGM in CD
pathogenesis.
Similarly complex roles emerge for the GBPs as well.
For example, GBP1 localizes to gap junctions in polarized human
intestinal epithelial cells to inhibit enteropathogenic E. coli-
induced apoptosis (Mirpuri et al., 2010; Schnoor et al., 2009). A
more recent report, however, suggests that this GTPase can
also block epithelial cell proliferation by interfering with b-catenin
signaling (Capaldo et al., 2012). Definitive chromosomal dele-
tions of the human GBP1 locus may help resolve some of these
issues as they relate to host defense operating within the gastro-
intestinal mucosa.
Concluding Remarks
GTPases serve protean roles in every mammalian organ system,
from synaptic vesicle trafficking to neutrophil chemotaxis to ion
channel transport for glomerular filtration in the kidney (Colicelli,
2004). These and other physiological activities are subsumed by
>180 GTPases in humans encompassing the RAS, RAC, RAB,
RHO, ARF, dynamin, and atlastin families (Colicelli, 2004).
Emergence of an IFN-inducible GTPase superfamily with dedi-
cated cell-autonomous defense functions adds another dimen-
sion to the sphere of biological reactions driven by guanine
nucleotide binding and hydrolysis. That the IFN-inducible
GTPases seem to have evolved highly pathogen-specific and
subclass-dependent activities to defend the cell’s interior is
a remarkable adaptation on the part of larger vertebrate hosts
(Figure 6). Presumably, such adaptations come with a fitness
cost, however, since most immune GTPases are placed under
strict transcriptional, epigenetic, and posttranslational control
(MacMicking, 2012).Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 441
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ReviewA number of outstanding questions remain regarding the
biology of these new proteins, chief among them being the
precise manner in which patterns of intracellular discrimination
and defense are deployed. For example, what are the surface
structures recognized by IRGs, GBPs, MX proteins, and possibly
GVINs on membrane compartments harboring different
bacteria, protozoa and viruses? Similarly, how do IFN-inducible
GBPs detect cytosolically escaped bacteria, and does detection
uniformly lead to inflammasome activation or autophagic engulf-
ment? What are the host effector pathways solicited by different
GTPase family members to restrict microbial replication, and, of
equal importance, what are the pathogen-encoded tactics used
to evade them? Recent evidence in Toxoplasma and Chlamydia
and in HCV, HIV-1, and Measles virus point to multiple mecha-
nisms for avoiding or manipulating the antimicrobial action of
at least some IRGs and GBPs in their natural hosts (Fentress
et al., 2010; Fleckenstein et al., 2012; Gre´goire et al., 2011; Itsui
et al., 2009; Niedelman et al., 2012; Steinfeldt et al., 2010; Virreira
Winter et al., 2011). Future efforts should unearth others.
Lastly, the acquisition of such microbial strategies implies that
a strong selective pressure is placed by the IFN-inducible
GTPases on intracellular pathogens irrespective of their replica-
tive lifestyle. Harnessing that power for clinical benefit would
represent a ‘‘first’’ in the field of cell-autonomous immunity and
help answer the call for fresh approaches to anti-infective thera-
pies (Nathan, 2012).ACKNOWLEDGMENTS
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